S. Gracon
Impact in
- Psychiatry and Mental health top 5%
- Dementia and Cognitive Impairment Research
- Pharmacology top 2%
- Cholinesterase and Neurodegenerative Diseases
Papers in
-
- Cholinesterase and Neurodegenerative Diseases 6
-
- Dementia and Cognitive Impairment Research 5
- Co-authors
- Toni M. Hoover (4 shared papers)David S. Knopman (3 shared papers)Keith L. Davis (2 shared papers)Lon S. S. Schneider (1 shared paper)Fraser Smith (1 shared paper)Sheela Talwalker (1 shared paper)E. Gamzu (3 shared papers)Leon J. Thal (1 shared paper)
- Journals
- Neurology (3 papers)The Lancet (2 papers)Toxicology and Applied Pharmacology (1 paper)JAMA (1 paper)Acta Neurologica Scandinavica (1 paper)
- Partner nations
- United StatesFranceIndia
In The Last Decade
S. Gracon
15 papers receiving 1.1k citations
S. Gracon's Hit Papers
Peers
Comparison fields: 5 of 93
- Psychiatry and Mental health 438
- Pharmacology 415
- Physiology 375
- Neurology 115
- Geriatrics and Gerontology 42
Countries citing papers authored by S. Gracon
This map shows the geographic impact of S. Gracon's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by S. Gracon with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites S. Gracon more than expected).
Fields of papers citing papers by S. Gracon
This network shows the impact of papers produced by S. Gracon. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by S. Gracon. The network helps show where S. Gracon may publish in the future.
Co-authors
The 25 scholars most cited alongside S. Gracon, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | A Double-Blind, Placebo-Controlled Multicenter Study of Tacrine for Alzheimer's Disease Hit paper breakdown → | 1992 | 534 |
| 2 | 1996 | 251 | |
| 3 | 2003 | 246 | |
| 4 | 2011 | 68 | |
| 5 | 1995 | 26 | |
| 6 | 1996 | 16 | |
| 7 | 1996 | 14 | |
| 8 | 1991 | 9 | |
| 9 | 1998 | 6 | |
| 10 | 1982 | 5 | |
| 11 | 1988 | 4 | |
| 12 | 1993 | 4 | |
| 13 | 1996 | 3 | |
| 14 | 1990 | 1 | |
| 15 | [Advantages in long-term treatment with Cognex in Alzheimer disease]. | 1997 | 1 |
About S. Gracon
S. Gracon is a scholar working on Pharmacology, Psychiatry and Mental health, Physiology, Sensory Systems and Oncology, having authored 15 papers that have together received 1.2k indexed citations. Recurring topics across this work include Cholinesterase and Neurodegenerative Diseases (6 papers), Dementia and Cognitive Impairment Research (5 papers), Alzheimer's disease research and treatments (5 papers), Olfactory and Sensory Function Studies (2 papers), Nuclear Structure and Function (1 paper), Medicinal Plants and Neuroprotection (1 paper), Polyomavirus and related diseases (1 paper) and RNA regulation and disease (1 paper). The work is most often cited by research in Psychiatry and Mental health (438 citations), Pharmacology (415 citations), Physiology (375 citations), Neurology (115 citations) and Geriatrics and Gerontology (42 citations). S. Gracon has collaborated with scholars based in United States, France and India. Frequent co-authors include Toni M. Hoover, David S. Knopman, Keith L. Davis, Lon S. S. Schneider, Fraser Smith, Sheela Talwalker, E. Gamzu, Leon J. Thal, Peter John Whitehouse and Ch Davis. Their work appears in journals such as Neurology, The Lancet, Toxicology and Applied Pharmacology, JAMA and Acta Neurologica Scandinavica.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.